Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
0.6138
-0.0180 (-2.85%)
At close: Nov 19, 2026, 4:00 PM EST
0.6260
+0.0122 (1.99%)
After-hours: Nov 19, 2026, 7:45 PM EST
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $23.21 million as of November 19, 2026. It is the 35,388th most valuable company in the world and the 5,028th biggest in the United States. Its market cap has decreased by 63.65% in one year.
Market Cap
23.21M
Enterprise Value
-42.26M
1-Year Change
-63.65%
Global Rank
Country Rank
#5,028 United States
Category
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $23.21M, a decrease of -95.88%. That is a compound annual growth rate of -68.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 23.21M | -61.85% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 27.57M |
| Pelthos Therapeutics | 27.37M |
| Polyrizon | 25.99M |
| Lite Strategy | 25.60M |
| Evaxion | 25.55M |
| Edesa Biotech | 25.54M |
| CervoMed | 25.26M |
| ABVC BioPharma | 24.41M |